3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
4
Oropharyngeal Neoplasms
3
Laryngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Mouth Neoplasms
2
Mesothelioma
2
Hypopharyngeal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Astrocytoma
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Nasopharyngeal Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Carcinoma, Squamous Cell
1
Interventions
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nivolumab
3
ulixertinib
2
dabrafenib
2
binimetinib
2
Sunitinib
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Cetuximab
2
CTLA-4 Antigen
2
Biopsy
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipifarnib
1
temsirolimus
1
selpercatinib
1
sapanisertib
1
repotrectinib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.